Please login to the form below

Not currently logged in
Email:
Password:

INC Research expands infectious diseases team with appointment of Dr Frederick Young

He joins the CRO from ICON, where he served as vice president of strategic programmes

INC Research has appointed ICON's former vice president of strategic programmes Dr Frederick Young as vice president of infectious diseases.

The contract research organisation (CRO) says the addition of Dr Young will support its work in global vaccine development research as well as expanding its infectious diseases team.

"Antibiotics and other antimicrobials have played a critical role in the fight against infectious diseases, but further discovery and evaluation of new treatments is still needed," said Patricia Monteforte, executive vice president and general manager, general medicine, INC Research.

"We've become a leader in infectious diseases research by having a therapeutically-focused team with experience in all stages and disciplines associated with the development of anti-infectives. With the addition of Frederick, INC Research is positioned to expand this therapeutic unit even further with experienced resources to support and advance our customers' research and development."

Prior to his time with ICON, where he worked for nearly four years, Dr Young served at Novartis in a number of roles, including clinical research scientist, executive director, project leader and, most recently, global programme director.

25th April 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics